Moore Capital Management »

Biomarin Pharma Inc convertible/ shares owned by Moore Capital Management

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $13M 13M 0.99

More positions owned by Moore Capital Management

Amazon (AMZN)
salesforce (CRM)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Energy (XLE)
Microsoft Corporation (MSFT)
Vertiv Holdings Com Cl A (VRT)
Digital Realty Trust (DLR)
Ally Financial (ALLY)
Freeport-mcmoran CL B (FCX)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vaneck Etf Trust Semiconductr Etf (SMH)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Uber Technologies (UBER)

View all positions for Moore Capital Management

Top funds holding Biomarin Pharma Inc convertible/

Lord, Abbett & Co
Lazard Asset Management
Bank of America Corporation
Millennium Management
Citigroup
Aviva
Sona Asset Management
Tenor Capital Management
Shaolin Capital Management
Sunrise Partners Limited Partnership
Partner Fund Management
Moore Capital Management
State Street Corporation
Thrivent Financial for Lutherans
MacKay Shields

View all funds holding Biomarin Pharma Inc convertible/